Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, usually aggressive, primary thymic carcinoma, characterized by the presence of tumor cells morphologically resembling soft tissue sarcoma.
Biomarker and diagnostic research for thymic sarcomatoid carcinoma has been reported in the published literature.
No clinical trials have been registered for thymic sarcomatoid carcinoma.
117 publications have been identified in PubMed for thymic sarcomatoid carcinoma. Kisho has analyzed 81 by research type. Research spans Review / Meta-Analysis (33%), Clinical Trial Publication (15%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 27 | 33% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 7:37 AM UTC
Clinical study results
12 |
15% |
Disease patterns and progression | 11 | 14% |
Testing and diagnosis research | 10 | 12% |
Patient case studies | 10 | 12% |
Laboratory research | 10 | 12% |
New treatment approaches | 1 | 1% |
Maniar R (2026). [PMID: 41825128](https://pubmed.ncbi.nlm.nih.gov/41825128/). *J Natl Compr Canc Netw*. [Review / Meta-Analysis]
Bernatz S (2026). [PMID: 41851467](https://pubmed.ncbi.nlm.nih.gov/41851467/). *Nature*. [Clinical Trial Publication]
Fang W (2026). [PMID: 41016430](https://pubmed.ncbi.nlm.nih.gov/41016430/). *J Thorac Oncol*. [Review / Meta-Analysis]
Resio BJ (2026). [PMID: 40865907](https://pubmed.ncbi.nlm.nih.gov/40865907/). *J Thorac Oncol*. [Epidemiology / Natural History]
Gu SM (2026). [PMID: 41496339](https://pubmed.ncbi.nlm.nih.gov/41496339/). *Biomed Pharmacother*. [Review / Meta-Analysis]
Sacco M (2026). [PMID: 41390119](https://pubmed.ncbi.nlm.nih.gov/41390119/). *Ann Oncol*. [Diagnostic / Biomarker]
Agaimy A (2026). [PMID: 40913630](https://pubmed.ncbi.nlm.nih.gov/40913630/). *Virchows Arch*. [Basic Science / Preclinical]
Haddock ML (2026). [PMID: 41792801](https://pubmed.ncbi.nlm.nih.gov/41792801/). *J Cardiothorac Surg*. [Case Report / Case Series]
Canaslan K (2026). [PMID: 41843177](https://pubmed.ncbi.nlm.nih.gov/41843177/). *Cancer Immunol Immunother*. [Review / Meta-Analysis]
Ida A (2026). [PMID: 42098011](https://pubmed.ncbi.nlm.nih.gov/42098011/). *Kyobu Geka*. [Case Report / Case Series]